Browse by Audience
Skip to content
Papers of the Week
Effect of KATP channel blocker glibenclamide on levcromakalim-induced headache.
Authors
Abstract
Administration of ATP-sensitive potassium channel opener levcromakalim triggers headache in healthy volunteers and migraine attacks in migraine patients. Here, we investigated the effect of ATP-sensitive potassium channel blocker glibenclamide on levcromakalim-induced headache in healthy volunteers.